Maximizing cardiopulmonary support as a minimally invasive platform—using peripheral parallel veno-venous and veno-arterial extracorporeal membrane oxygenation and axillary impella 5.5 as a bridge to heart–lung transplantation
Maximizing cardiopulmonary support as a minimally invasive platform—using peripheral parallel veno-venous and veno-arterial extracorporeal membrane oxygenation and axillary impella 5.5 as a bridge to heart–lung transplantation. // JHLT Open. – URL: https://www.sciencedirect.com/science/article/pii/S2950133426002053?dgcid=rss_sd_all
Maximizing cardiopulmonary support as a minimally invasive platform—using peripheral parallel veno-venous and veno-arterial extracorporeal membrane oxygenation and axillary impella 5.5 as a bridge to heart–lung transplantation. JHLT Open. https://www.sciencedirect.com/science/article/pii/S2950133426002053?dgcid=rss_sd_all
“Maximizing cardiopulmonary support as a minimally invasive platform—using peripheral parallel veno-venous and veno-arterial extracorporeal membrane oxygenation and axillary impella 5.5 as a bridge to heart–lung transplantation.” JHLT Open.
@article{article51271,
title = {Maximizing cardiopulmonary support as a minimally invasive platform—using peripheral parallel veno-venous and veno-arterial extracorporeal membrane oxygenation and axillary impella 5.5 as a bridge to heart–lung transplantation},
journal = {JHLT Open},
url = {https://www.sciencedirect.com/science/article/pii/S2950133426002053?dgcid=rss_sd_all}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...